Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury

NCT ID: NCT04165369

Last Updated: 2022-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10568 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-09

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials.

The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute kidney injury (AKI) is a severe clinical complication with increasing incidence and is associated with adverse short- and long-term outcomes resulting in a major health care burden worldwide. The introduction of consensus classification systems has enhanced the awareness for AKI. The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. However, analyzing AKI from existing databases is often limited by missing data elements, especially the inclusion of the urine output criteria. Missing data and the use of different definitions before the consensus classification are the reasons for large variations in reported occurrences of surgical induced AKI.

The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit (e.g., Intensive Care Unit, Intermediate Care, Post Anesthesia Care Unit) using the latest consensus definition for AKI (Kidney Disease: Improving Global Outcomes criteria) and a standardized data collection instrument and to assess the dependence of AKI on preoperative and intraoperative factors.

Method: International prospective, observational, multi-center, cross-sectional cohort study

Eligible patients will be identified during preoperative assessment. All eligible patients will be approached to obtain written consent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury (AKI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with extended surgical exposures

Patients with extended surgical exposures requiring postoperative observation.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* major elective or emergency surgery procedures with a duration of at least 2 h
* admission to the intensive care unit, intermediate care unit after surgery informed consent

Exclusion Criteria

* preexisting acute kidney injury
* acute kidney injury within the last 3 months
* end stage renal disease with dialysis dependency
* kidney transplant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baxter Healthcare Corporation

INDUSTRY

Sponsor Role collaborator

University Hospital Muenster

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexander Zarbock, MD, PhD

Role: STUDY_CHAIR

University Hospital Muenster, Dept. of Anesthesiology, Intensive Care and Pain Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama

Birmingham, Alabama, United States

Site Status

Mansoura University Hospitals

Al Mansurah, , Egypt

Site Status

Alexandria University

Alexandria, , Egypt

Site Status

Tanta University Faculty of Medicine

Tanta, , Egypt

Site Status

CHU d'Angers

Angers, , France

Site Status

Centre Hospitalier Simone Veil de Blois

Blois, , France

Site Status

CHU de Bordeaux

Bordeaux, , France

Site Status

Centre de Lutte contre le Cancer Francois Baclesse

Caen, , France

Site Status

Hopital Privé Sévigné

Cesson-Sévigné, , France

Site Status

Hopital Huriez - CHU de Lille

Lille, , France

Site Status

Clinique Chénieux

Limoges, , France

Site Status

Hopital Edouard Herriot

Lyon, , France

Site Status

Centre Hospitalier des Pays de Morlaix

Morlaix, , France

Site Status

CHU de Nices

Nice, , France

Site Status

Hopital Bichat

Paris, , France

Site Status

Hopital Maison Blance

Reims, , France

Site Status

Clinique Sainte-Anne

Strasbourg, , France

Site Status

CHG Tarbes

Tarbes, , France

Site Status

Clinique Pasteur Toulouse

Toulouse, , France

Site Status

Hopital Robert Schuman-Groupe UNEOS

Vantoux, , France

Site Status

Gustave Roussy

Villejuif, , France

Site Status

Kliniken Maria Hilf

Mönchengladbach, , Germany

Site Status

Herz Jesu Krankenhaus Münster Hiltrup

Münster, , Germany

Site Status

University Hospital Muenster

Münster, , Germany

Site Status

St. Josef-Stift Sendenhorst

Sendenhorst, , Germany

Site Status

Universitätsklinikum Tübingen

Tübingen, , Germany

Site Status

Ospedale di Montebelluna

Montebelluna, , Italy

Site Status

University of Palermo

Palermo, , Italy

Site Status

Cardioanestesia - Azienda Ospedaliera San Carlo di Potenza

Potenza, , Italy

Site Status

Ospedale Sant'Eugenio di Roma

Rome, , Italy

Site Status

National Heart Center Tripoli

Tripoli, , Libya

Site Status

Tripoli Central Hospital

Tripoli, , Libya

Site Status

Mater Dei Hospital

Birkirkara, , Malta

Site Status

University Clinic

Skopje, , North Macedonia

Site Status

Al-Shifa Medical Complex

Gaza, , Palestinian Territories

Site Status

Alia Governmental Hospital

Hebron, , Palestinian Territories

Site Status

Kemerovo Cardiology Centre

Kemerovo, , Russia

Site Status

Bakulev Scientific Center for Cardiovascular Surgery

Moscow, , Russia

Site Status

Polenov Neurosurgical Institute

Saint Petersburg, , Russia

Site Status

Almana General Hospital

Khobar, , Saudi Arabia

Site Status

University Medical Centre Maribor

Ljubljana, , Slovenia

Site Status

Splosna bolnisnica Murska Sobota

Murska Sobota, , Slovenia

Site Status

Hospital Universitario Araba

Alava, , Spain

Site Status

Hospital Universitario Funcacion Alcorcón

Alcorcón, , Spain

Site Status

Urology Fundación Puigvert

Barcelona, , Spain

Site Status

Donostia University Hospital

Donostia / San Sebastian, , Spain

Site Status

Hospital Cliínico Universitario Virgen de las Nieves

Granada, , Spain

Site Status

Hospital Universitario de Gran Canaria Doctor Negrin

Las Palmas de Gran Canaria, , Spain

Site Status

San Pedro Hospital

Logroño, , Spain

Site Status

Hospital Ramón y Cajal

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Infanta Leonor University Hospital

Madrid, , Spain

Site Status

Son Llatzer University Hospital

Palma de Mallorca, , Spain

Site Status

Cukurova University

Adana, , Turkey (Türkiye)

Site Status

Akdeniz University Hospital

Akdeniz, , Turkey (Türkiye)

Site Status

Ankara City Hospital

Ankara, , Turkey (Türkiye)

Site Status

Ibn Sina Hospital

Ankara, , Turkey (Türkiye)

Site Status

Kahramanmaras Sutcu Imam University

Ankara, , Turkey (Türkiye)

Site Status

Balikesir University

Balıkesir, , Turkey (Türkiye)

Site Status

Uludag University

Bursa, , Turkey (Türkiye)

Site Status

University of Health Sciences

Bursa, , Turkey (Türkiye)

Site Status

Health Sciences University Medical School

Derince, , Turkey (Türkiye)

Site Status

Düzce University

Düzce, , Turkey (Türkiye)

Site Status

Gazi University Hospital

Gazi, , Turkey (Türkiye)

Site Status

Acibadem MAA Ünv. Altunizade Ä'Acibadem

Istanbul, , Turkey (Türkiye)

Site Status

Acibadem MAA Ünv. Atakent Acibadem

Istanbul, , Turkey (Türkiye)

Site Status

Haseki Egitim Arastirma

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul University - Cerrahpasa

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul University

Istanbul, , Turkey (Türkiye)

Site Status

Koc University Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Prof. Dr. Cemil Tascioglu City Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Yeditepe

Istanbul, , Turkey (Türkiye)

Site Status

Dokuz Eylül Üniversitesi

Izmir, , Turkey (Türkiye)

Site Status

Izmir Democracy University School of Medicine

Izmir, , Turkey (Türkiye)

Site Status

Health Sciences University Kartal

Kartal, , Turkey (Türkiye)

Site Status

Inönü University Hospital

Malatya, , Turkey (Türkiye)

Site Status

Manisa, Medical Faculty

Manisa, , Turkey (Türkiye)

Site Status

Suleyman Demirel University School of Medicine

Merkez, , Turkey (Türkiye)

Site Status

Mersin University

Mersin, , Turkey (Türkiye)

Site Status

Mayis University

Samsun, , Turkey (Türkiye)

Site Status

Karadeniz Technical University

Trabzon, , Turkey (Türkiye)

Site Status

University Faculty of Medicine

Trakya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Egypt France Germany Italy Libya Malta North Macedonia Palestinian Territories Russia Saudi Arabia Slovenia Spain Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Meersch M, Weiss R, Strauss C, Albert F, Booke H, Forni L, Pittet JF, Kellum JA, Rosner M, Mehta R, Bellomo R, Rosenberger P, Zarbock A; EPIS-AKI Investigators. Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial. Intensive Care Med. 2024 Feb;50(2):247-257. doi: 10.1007/s00134-023-07314-2. Epub 2024 Jan 29.

Reference Type DERIVED
PMID: 38285051 (View on PubMed)

Zarbock A, Weiss R, Albert F, Rutledge K, Kellum JA, Bellomo R, Grigoryev E, Candela-Toha AM, Demir ZA, Legros V, Rosenberger P, Galan Menendez P, Garcia Alvarez M, Peng K, Leger M, Khalel W, Orhan-Sungur M, Meersch M; EPIS-AKI Investigators. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023 Dec;49(12):1441-1455. doi: 10.1007/s00134-023-07169-7. Epub 2023 Jul 28.

Reference Type DERIVED
PMID: 37505258 (View on PubMed)

Weiss R, Saadat-Gilani K, Kerschke L, Wempe C, Meersch M, Zarbock A; EPIS-AKI Investigators. EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): study protocol for a multicentre, observational trial. BMJ Open. 2021 Dec 30;11(12):e055705. doi: 10.1136/bmjopen-2021-055705.

Reference Type DERIVED
PMID: 35588372 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

01-AnIt-19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.